SAM
MRNA icon

Shell Asset Management’s Moderna MRNA Stock Holding History

Shell Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-464
Closed -$13K – 1231
2025
Q2 		$13K Sell
464
-531
-53% -$14K ﹤0.01% 1245
2025
Q1 		$28K Hold
995
– – ﹤0.01% 1211
2024
Q4 		$41K Hold
995
– – ﹤0.01% 1197
2024
Q3 		$66K Buy
+995
New +$91.4K ﹤0.01% 1140
2024
Q1 		$118K Sell
995
-694
-41% -$70K 0.01% 976
2023
Q4 		$168K Sell
1,689
-4,160
-71% -$350K 0.01% 914
2023
Q3 		$604K Buy
5,849
+71
+1% +$7.92K 0.03% 488
2023
Q2 		$702K Sell
5,778
-2,973
-34% -$397K 0.03% 463
2023
Q1 		$1.34M Sell
8,751
-41
-0.5% -$6.76K 0.06% 317
2022
Q4 		$1.58M Sell
8,792
-3,433
-28% -$561K 0.07% 282
2022
Q3 		$1.45M Sell
12,225
-2,873
-19% -$436K 0.06% 309
2022
Q2 		$2.16M Buy
15,098
+831
+6% +$119K 0.06% 292
2022
Q1 		$2.46M Buy
14,267
+45
+0.3% +$7.58K 0.06% 299
2021
Q4 		$3.61M Buy
14,222
+128
+0.9% +$37.4K 0.07% 249
2021
Q3 		$5.42M Buy
14,094
+228
+2% +$84.1K 0.12% 183
2021
Q2 		$3.26M Buy
13,866
+6,803
+96% +$1.22M 0.06% 279
2021
Q1 		$925K Buy
7,063
+318
+5% +$46.1K 0.02% 565
2020
Q4 		$705K Buy
6,745
+5,175
+330% +$524K 0.01% 629
2020
Q3 		$111K Hold
1,570
– – ﹤0.01% 1150
2020
Q2 		$101K Buy
+1,570
New +$86K ﹤0.01% 1146

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Shell Asset Management's MRNA Position: Q3 2025 in Review

Shell Asset Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 464 shares — an estimated $13K sold.

Shell Asset Management first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $5.42M in Q3 2021. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Shell Asset Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Shell Asset Management sold 464 Moderna shares in Q3 2025, an estimated $13K.
  • Shell Asset Management first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Shell Asset Management's Moderna position peaked at $5.42M in Q3 2021.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.